{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T10:51:53Z","timestamp":1769856713371,"version":"3.49.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.yexcr.2019.01.001","type":"journal-article","created":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T11:36:49Z","timestamp":1546429009000},"page":"98-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Implications of scar structure and mechanics for post-infarction cardiac repair and regeneration"],"prefix":"10.1016","volume":"376","author":[{"given":"Brent A.","family":"French","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey W.","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2019.01.001_bib1","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1001\/jamacardio.2016.2225","article-title":"Adult stem cell therapy and heart failure, 2000 to 2016: a systematic review","volume":"1","author":"Nguyen","year":"2016","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.yexcr.2019.01.001_bib2","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1038\/nm.3764","article-title":"An emerging consensus on cardiac regeneration","volume":"20","author":"Van Berlo","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.yexcr.2019.01.001_bib3","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1161\/CIRCRESAHA.118.311217","article-title":"Clinical studies of cell therapy in cardiovascular medicine","volume":"123","author":"Banerjee","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.yexcr.2019.01.001_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/s41569-018-0036-6","article-title":"Therapeutic approaches for cardiac regeneration and repair","author":"Hashimoto","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.yexcr.2019.01.001_bib5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/cpt.724","article-title":"Engineered heart repair","volume":"102","author":"Fujita","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.yexcr.2019.01.001_bib6","doi-asserted-by":"crossref","first-page":"363ra148","DOI":"10.1126\/scitranslmed.aaf8781","article-title":"Cardiac repair in guinea pigs with human engineered heart tissue from induced pluripotent stem cells","volume":"8","author":"Weinberger","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.yexcr.2019.01.001_bib7","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1161\/CIRCULATIONAHA.114.014998","article-title":"Mechanical stress conditioning and electrical stimulation promote contractility and force maturation of induced pluripotent stem cell-derived human cardiac tissue","volume":"134","author":"Ruan","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.yexcr.2019.01.001_bib8","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.jtcvs.2011.07.002","article-title":"Novel regenerative therapy using cell-sheet covered with omentum flap delivers a huge number of cells in a porcine myocardial infarction model","volume":"142","author":"Shudo","year":"2011","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.yexcr.2019.01.001_bib9","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/CIRCRESAHA.115.306985","article-title":"Human engineered heart muscles engraft and survive long term in a rodent myocardial infarction model","volume":"117","author":"Riegler","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.yexcr.2019.01.001_bib10","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/CIRCRESAHA.109.200386","article-title":"Human studies of angiogenic gene therapy","volume":"105","author":"Gupta","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.yexcr.2019.01.001_bib11","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0140-6736(04)16626-9","article-title":"Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial","volume":"364","author":"Wollert","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.yexcr.2019.01.001_bib12","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1001\/jama.2011.1670","article-title":"Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial","volume":"306","author":"Traverse","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.yexcr.2019.01.001_bib13","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1001\/jama.2012.28726","article-title":"Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial","volume":"308","author":"Traverse","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.yexcr.2019.01.001_bib14","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1161\/CIRCRESAHA.116.308639","article-title":"Effect of bone marrow-derived mononuclear cell treatment, early or late after acute myocardial infarction: twelve months CMR and long-term clinical results","volume":"119","author":"S\u00fcrder","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.yexcr.2019.01.001_bib15","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1161\/CIRCRESAHA.115.308165","article-title":"PreSERVE-AMI: a randomized, double-blind, placebo-controlled clinical trial of intracoronary administration of autologous CD34+ cells in patients with left ventricular dysfunction post STEMI","volume":"120","author":"Quyyumi","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.yexcr.2019.01.001_bib16","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1093\/eurheartj\/ehx188","article-title":"Intracoronary autologous bone marrow cell transfer after myocardial infarction: the BOOST-2 randomised placebo-controlled clinical trial","volume":"38","author":"Wollert","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.yexcr.2019.01.001_bib17","first-page":"169","article-title":"The Athena trials: autologous adipose-derived regenerative cells for refractory chronic myocardial ischemia with left ventricular dysfunction","volume":"89","author":"Henry","year":"2017","journal-title":"Catheter Cardiovasc. Interv."},{"key":"10.1016\/j.yexcr.2019.01.001_bib18","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1001\/jama.2012.25321","article-title":"Comparison of allogeneic vs autologous bone marrow\u2013derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial","volume":"308","author":"Hare","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.yexcr.2019.01.001_bib19","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1161\/CIRCULATIONAHA.112.092627","article-title":"Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance","volume":"126","author":"Chugh","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.yexcr.2019.01.001_bib20","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1161\/CIRCRESAHA.118.312978","article-title":"Rationale and design of the CONCERT-HF trial (combination of mesenchymal and c-kit+ cardiac stem cells as regenerative therapy for heart failure)","volume":"122","author":"Bolli","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.yexcr.2019.01.001_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/d41586-018-07232-0","article-title":"US government halts heart stem-cell study","author":"Reardon","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2019.01.001_bib22","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.jacc.2010.05.039","article-title":"Rebuilding the damaged heart: the potential of cytokines and growth factors in the treatment of ischemic heart disease","volume":"56","author":"Beohar","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.yexcr.2019.01.001_bib23","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1161\/CIRCULATIONAHA.105.541433","article-title":"Preservation from left ventricular remodeling by front-integrated revascularization and stem cell liberation in evolving acute myocardial infarction by use of granulocyte-colony-stimulating factor (FIRSTLINE-AMI)","volume":"112","author":"Ince","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.yexcr.2019.01.001_bib24","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1161\/CIRCULATIONAHA.117.029343","article-title":"Cardiomyocyte regeneration: a consensus statement","volume":"136","author":"Eschenhagen","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.yexcr.2019.01.001_bib25","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1126\/science.1164680","article-title":"Evidence for cardiomyocyte renewal in humans","volume":"324","author":"Bergmann","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.yexcr.2019.01.001_bib26","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nature11682","article-title":"Mammalian heart renewal by pre-existing cardiomyocytes","volume":"493","author":"Senyo","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2019.01.001_bib27","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.cell.2009.04.060","article-title":"Neuregulin1\/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury","volume":"138","author":"Bersell","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.yexcr.2019.01.001_bib28","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nature15372","article-title":"Epicardial FSTL1 reconstitution regenerates the adult mammalian heart","volume":"525","author":"Wei","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2019.01.001_bib29","doi-asserted-by":"crossref","first-page":"13839","DOI":"10.1073\/pnas.1313192110","article-title":"Hippo pathway effector Yap promotes cardiac regeneration","volume":"110","author":"Xin","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.yexcr.2019.01.001_bib30","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/CIRCRESAHA.115.303632","article-title":"Cardiac-specific YAP activation improves cardiac function and survival in an experimental murine MI model","volume":"115","author":"Lin","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.yexcr.2019.01.001_bib31","doi-asserted-by":"crossref","first-page":"279ra38","DOI":"10.1126\/scitranslmed.3010841","article-title":"A microRNA-Hippo pathway that promotes cardiomyocyte proliferation and cardiac regeneration in mice","volume":"7","author":"Tian","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.yexcr.2019.01.001_bib32","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/nature24045","article-title":"Hippo pathway deficiency reverses systolic heart failure after infarction","volume":"550","author":"Leach","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2019.01.001_bib33","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1161\/01.RES.0000152326.91223.4F","article-title":"Targeted expression of cyclin D2 results in cardiomyocyte DNA synthesis and infarct regression in transgenic mice","volume":"96","author":"Pasumarthi","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.yexcr.2019.01.001_bib34","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1161\/CIRCRESAHA.112.300658","article-title":"mir-17-92 cluster is required for and sufficient to induce cardiomyocyte proliferation in postnatal and adult hearts","volume":"112","author":"Chen","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.yexcr.2019.01.001_bib35","doi-asserted-by":"crossref","DOI":"10.1126\/science.aan4672","article-title":"Gene therapy comes of age","author":"Dunbar","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.yexcr.2019.01.001_bib36","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/jgm.2673","article-title":"Adeno-associated virus serotype 9 administered systemically after reperfusion preferentially targets cardiomyocytes in the infarct border zone with pharmacodynamics suitable for the attenuation of left ventricular remodeling","volume":"14","author":"Konkalmatt","year":"2008","journal-title":"J. Gene Med."},{"key":"10.1016\/j.yexcr.2019.01.001_bib37","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/nbt.2682","article-title":"Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction","volume":"31","author":"Zangi","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.yexcr.2019.01.001_bib38","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1126\/science.aat5011","article-title":"CRISPR-Cas guides the future of genetic engineering","volume":"361","author":"Knott","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.yexcr.2019.01.001_bib39","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.cell.2010.07.002","article-title":"Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors","volume":"142","author":"Ieda","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.yexcr.2019.01.001_bib40","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/nature11044","article-title":"In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes","volume":"485","author":"Qian","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2019.01.001_bib41","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nature11139","article-title":"Heart repair by reprogramming non-myocytes with cardiac transcription factors","volume":"485","author":"Song","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2019.01.001_bib42","doi-asserted-by":"crossref","first-page":"e89678","DOI":"10.1371\/journal.pone.0089678","article-title":"Inhibition of TGF\u03b2 signaling increases direct conversion of fibroblasts to induced cardiomyocytes","volume":"9","author":"Ifkovits","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.yexcr.2019.01.001_bib43","doi-asserted-by":"crossref","first-page":"8243","DOI":"10.1038\/ncomms9243","article-title":"High-efficiency reprogramming of fibroblasts into cardiomyocytes requires suppression of pro-fibrotic signalling","volume":"6","author":"Zhao","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yexcr.2019.01.001_bib44","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/gt.2016.20","article-title":"Systemic injection of AAV9 carrying a periostin promoter targets gene expression to a myofibroblast-like lineage in mouse hearts after reperfused myocardial infarction","volume":"23","author":"Piras","year":"2016","journal-title":"Gene Ther."},{"key":"10.1016\/j.yexcr.2019.01.001_bib45","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/j.2040-4603.2015.tb00658.x","article-title":"Physiological implications of myocardial scar structure","volume":"5","author":"Richardson","year":"2015","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.yexcr.2019.01.001_bib46","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1161\/CIRCULATIONAHA.111.056952","article-title":"Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia\/reperfusion injury","volume":"125","author":"Barallobre-Barreiro","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.yexcr.2019.01.001_bib47","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12014-016-9120-2","article-title":"Adapting extracellular matrix proteomics for clinical studies on cardiac remodeling post-myocardial infarction","volume":"13","author":"Lindsey","year":"2016","journal-title":"Clin. Proteom."},{"key":"10.1016\/j.yexcr.2019.01.001_bib48","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.yjmcc.2009.06.012","article-title":"Extracellular matrix turnover and signaling during cardiac remodeling following MI: causes and consequences","volume":"48","author":"Zamilpa","year":"2010","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.yexcr.2019.01.001_bib49","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.yjmcc.2012.02.012","article-title":"Regional mechanics determine collagen fiber structure in healing myocardial infarcts","volume":"52","author":"Fomovsky","year":"2012","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.yexcr.2019.01.001_bib50","doi-asserted-by":"crossref","first-page":"4585","DOI":"10.1113\/jphysiol.2012.229484","article-title":"Mechanical regulation of fibroblast migration and collagen remodelling in healing myocardial infarcts","volume":"590","author":"Rouillard","year":"2012","journal-title":"J. Physiol."},{"key":"10.1016\/j.yexcr.2019.01.001_bib51","doi-asserted-by":"crossref","DOI":"10.1152\/ajpheart.00088.2018","article-title":"Surgical reinforcement alters collagen alignment and turnover in healing myocardial infarcts","author":"Caggiano","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.yexcr.2019.01.001_bib52","first-page":"I204","article-title":"Deleterious effects of methylprednisolone in patients with myocardial infarction","volume":"53","author":"Roberts","year":"1976","journal-title":"Circulation"},{"key":"10.1016\/j.yexcr.2019.01.001_bib53","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0002-9149(83)80148-9","article-title":"Scar thinning due to ibuprofen administration after experimental myocardial infarction","volume":"51","author":"Brown","year":"1983","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.yexcr.2019.01.001_bib54","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1161\/01.CIR.68.2.446","article-title":"Dose-dependent effects of short-term methylprednisolone on myocardial infarct extent, scar formation, and ventricular function","volume":"68","author":"Hammerman","year":"1983","journal-title":"Circulation"},{"key":"10.1016\/j.yexcr.2019.01.001_bib55","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1161\/01.CIR.67.6.1290","article-title":"Indomethacin-induced scar thinning after experimental myocardial infarction","volume":"67","author":"Hammerman","year":"1983","journal-title":"Circulation"},{"key":"10.1016\/j.yexcr.2019.01.001_bib56","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1172\/JCI112971","article-title":"Steroid administration after myocardial infarction promotes early infarct expansion. A study in the rat","volume":"79","author":"Mannisi","year":"1987","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yexcr.2019.01.001_bib57","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev.bioeng.7.060804.100453","article-title":"Structure and mechanics of healing myocardial infarcts","volume":"7","author":"Holmes","year":"2005","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.yexcr.2019.01.001_bib58","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/0021-9290(93)90030-I","article-title":"Measurement of strain and analysis of stress in resting rat left ventricular myocardium","volume":"26","author":"Omens","year":"1993","journal-title":"J. Biomech."},{"key":"10.1016\/j.yexcr.2019.01.001_bib59","doi-asserted-by":"crossref","first-page":"H221","DOI":"10.1152\/ajpheart.00495.2009","article-title":"Evolution of scar structure, mechanics, and ventricular function after myocardial infarction in the rat","volume":"298","author":"Fomovsky","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.yexcr.2019.01.001_bib60","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1083\/jcb.200405004","article-title":"Myotubes differentiate optimally on substrates with tissue-like stiffness: pathological implications for soft or stiff microenvironments","volume":"166","author":"Engler","year":"2004","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.yexcr.2019.01.001_bib61","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.cell.2006.06.044","article-title":"Matrix elasticity directs stem cell lineage specification","volume":"126","author":"Engler","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.yexcr.2019.01.001_bib62","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/22\/49\/494003","article-title":"Micro-and nanotechnology in cardiovascular tissue engineering","author":"Zhang","year":"2011","journal-title":"Nanotechnology"},{"key":"10.1016\/j.yexcr.2019.01.001_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/cshperspect.a014076","article-title":"Myocardial tissue engineering: In vitro models","volume":"4","author":"Vunjak Novakovic","year":"2014","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.yexcr.2019.01.001_bib64","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1021\/nl101355x","article-title":"Nanofiber assembly by rotary jet-spinning","volume":"10","author":"Badrossamay","year":"2010","journal-title":"Nano Lett."},{"key":"10.1016\/j.yexcr.2019.01.001_bib65","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/jbm.a.35217","article-title":"Tuning composition and architecture of biomimetic scaffolds for enhanced matrix synthesis by murine cardiomyocytes","volume":"103","author":"Gishto","year":"2015","journal-title":"J. Biomed. Mater. Res. - Part A"},{"key":"10.1016\/j.yexcr.2019.01.001_bib66","doi-asserted-by":"crossref","first-page":"5646","DOI":"10.1021\/acsnano.7b01062","article-title":"Interwoven aligned conductive nanofiber yarn\/hydrogel composite scaffolds for engineered 3D cardiac anisotropy","volume":"11","author":"Wu","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.yexcr.2019.01.001_bib67","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1039\/C7BM00323D","article-title":"Anisotropic microfibrous scaffolds enhance the organization and function of cardiomyocytes derived from induced pluripotent stem cells","volume":"5","author":"Wanjare","year":"2017","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.yexcr.2019.01.001_bib68","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nm1684","article-title":"Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart","volume":"14","author":"Ott","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.yexcr.2019.01.001_bib69","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.biomaterials.2015.04.056","article-title":"Acellular human heart matrix: a critical step toward whole heart grafts","volume":"61","author":"S\u00e1nchez","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.yexcr.2019.01.001_bib70","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.yjmcc.2016.03.008","article-title":"A computational model of cardiac fibroblast signaling predicts context-dependent drivers of myofibroblast differentiation","volume":"94","author":"Zeigler","year":"2016","journal-title":"J. Mol. Cell Cardiol."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482718309996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482718309996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T04:23:50Z","timestamp":1757996630000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482718309996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0014482718309996"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2019.01.001","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implications of scar structure and mechanics for post-infarction cardiac repair and regeneration","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2019.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}